Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii

A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii

(2017) Elias Dahdouh et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

(2017) J Nowak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii

(2016) Rafael López-Rojas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii

(2016) Xinli Mu et al.   Frontiers in Microbiology

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii

(2016) Mohd Hafidz Mahamad Maifiah et al.   Scientific Reports

Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii

(2015) Emanuele Durante-Mangoni et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital

(2015) Gati Noble Selasi et al.   INFECTION GENETICS AND EVOLUTION

Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii

(2015) Meritxell García-Quintanilla et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of Lipopolysaccharide

(2014) M. Garcia-Quintanilla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Growth Retardation, Reduced Invasiveness, and Impaired Colistin-Mediated Cell Death Associated with Colistin Resistance Development in Acinetobacter baumannii

(2013) Spyros Pournaras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial Fitness

(2013) Rafael López-Rojas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii

(2013) Alejandro Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

On the essentiality of lipopolysaccharide to Gram-negative bacteria

(2013) Ge Zhang et al.   CURRENT OPINION IN MICROBIOLOGY

Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment

(2013) E. S. Snitkin et al.   GENOME RESEARCH

Emergence of Colistin-Resistance in Extremely Drug-Resistant Acinetobacter baumannii Containing a Novel pmrCAB Operon During Colistin Therapy of Wound Infections

(2013) Emil Lesho et al.   JOURNAL OF INFECTIOUS DISEASES

Actividad de 18 agentes antimicrobianos frente a aislados clínicos de Acinetobacter baumannii: segundo estudio nacional multicéntrico (proyecto GEIH-REIPI-Ab 2010)

(2012) Felipe Fernández-Cuenca et al.   ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Colistin: an update on the antibiotic of the 21st century

(2012) Silpak Biswas et al.   Expert Review of Anti-Infective Therapy

Lipopolysaccharide-Deficient Acinetobacter baumannii Shows Altered Signaling through Host Toll-Like Receptors and Increased Susceptibility to the Host Antimicrobial Peptide LL-37

(2012) Jennifer H. Moffatt et al.   INFECTION AND IMMUNITY

Insertion Sequence ISAba11Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii

(2011) Jennifer H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine

(2011) Rebekah Henry et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System

(2011) Alejandro Beceiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumannii

(2011) Rafael López-Rojas et al.   JOURNAL OF INFECTIOUS DISEASES

Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production

(2010) J. H. Moffatt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vaccination with Outer Membrane Complexes Elicits Rapid Protective Immunity to Multidrug-ResistantAcinetobacter baumannii

(2010) Michael J. McConnell et al.   INFECTION AND IMMUNITY

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine

(2010) Michael J. McConnell et al.   VACCINE

Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System

(2009) M. D. Adams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Regulation ofAcinetobacter baumanniibiofilm formation

(2009) Jennifer A Gaddy et al.   Future Microbiology

Nosocomial Outbreak of Infection With Pan–Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital

(2009) Raquel Valencia et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective

(2009) María Fernández-Reyes et al.   PROTEOMICS